Erratum: Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' Acta Pharmaceutica Sinica B 12 (2022) 1198-1212.

Author: Yunhao WU ¹ ; Xiu YU ¹ ; Yuwei WANG ¹ ; Yalin HUANG ¹ ; Jiahui TANG ¹ ; Shuaishuai GONG ¹ ; Siyu JIANG ¹ ; Yuanli XIA ¹ ; Fang LI ¹ ; Boyang YU ¹ ; Yuanyuan ZHANG ¹ ; Junping KOU ¹
Author Information

1. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Publication Type:Published Erratum
From: Acta Pharmaceutica Sinica B 2022;12(7):3198-3199
CountryChina
Language:English
Abstract: [This corrects the article DOI: 10.1016/j.apsb.2021.09.017.].